| Vol. 15.18 – 18 May, 2023 |
| |
|
|
| Clinical-grade human umbilical cord-derived MSCs were administrated to two classic mouse models, and their effects on skeletal muscle mass and function were investigated by behavioral tests, immunostaining, and western blotting. [Cell Death & Disease] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors described a biomimetic placental barrier model from human trophoblast stem cells (hTSCs) in a perfused organ chip system. The placental barrier was constructed by co-culture of hTSCs and endothelial cells on the opposite sides of a collagen-coated membrane on chip. [Cell Proliferation] |
|
|
|
| Scientists aimed to optimize and maximize the therapeutic potential of human amniotic epithelial cells by pre-treating them with tumor necrosis factor-α and interferon-γ for ulcerative colitis treatment. [International Immunopharmacology] |
|
|
|
| The authors investigated whether delivery of miR-124 through human Wharton’s jelly MSCs derived exosomes could improve liver fibrosis. [International Immunopharmacology] |
|
|
|
| Investigators assessed the outcomes of patients who experienced graft failure after umbilical cord blood transplantation. [Bone Marrow Transplantation] |
|
|
|
| Researchers presented detailed methods to purify, culture, and functionally analyze human placental dNK, dTreg, dTem, and dMɸ from decidua parietalis. [Star Protocols] |
|
|
|
|
| Scientists provide an overview of placental development and highlight the instructional role of the epigenome in dictating cell fate decisions specifically in the placental trophoblast cell lineage. [Physiological Reviews] |
|
|
|
|
| The US FDA has approved an umbilical cord blood-based therapy for blood-cancer patients requiring a stem cell transplant. [Nature Biotechnology] |
|
|
|
|
| June 5 – 8, 2023 Winston-Salem, North Carolina, United States |
|
|
|
|
|
| University of Leipzig – Leipzig, Germany |
|
|
|
| Boehringer Ingelheim – Ingelheim, Germany |
|
|
|
| University of California San Francisco – San Francisco, California, United States |
|
|
|
| Roche Institute of Translational Bioengineering – Zurich, Switzerland |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
|